J
Javier R. Lama
Researcher at Asociación Civil Impacta Salud y Educación
Publications - 141
Citations - 11117
Javier R. Lama is an academic researcher from Asociación Civil Impacta Salud y Educación. The author has contributed to research in topics: Men who have sex with men & Population. The author has an hindex of 31, co-authored 127 publications receiving 9633 citations.
Papers
More filters
Journal ArticleDOI
Promote HIV Chemoprophylaxis Research, Don't Prevent It
Robert M. Grant,Susan Buchbinder,Willard Cates,Edith Clarke,Thomas J. Coates,Myron S. Cohen,Martin Delaney,Guiselly Flores,Pedro Goicochea,Gregg Gonsalves,Mark Harrington,Javier R. Lama,Kathleen M. MacQueen,John P. Moore,Leigh Peterson,Jorge Sanchez,Melanie A. Thompson,Mark A. Wainberg +17 more
TL;DR: The authors of this Policy Forum recommend involvement of community leaders and local investigators early in the development of research projects, open communication of accurate information about research, and active development of prevention and treatment infrastructure, which all serve to build the community trust that is the basis for research into finding ways to stop the spread of HIV/AIDS.
Journal ArticleDOI
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial
Rami Kantor,Laura M. Smeaton,Saran Vardhanabhuti,Sarah E. Hudelson,Carol L. Wallis,Srikanth Tripathy,Mariza G. Morgado,Shanmugham Saravanan,Pachamuthu Balakrishnan,Marissa B Reitsma,Stephen Hart,John W. Mellors,Elias K. Halvas,Beatriz Grinsztejn,Mina C. Hosseinipour,Johnstone Kumwenda,Alberto La Rosa,Umesh G. Lalloo,Javier R. Lama,Mohammed Rassool,Breno Santos,Khuanchai Supparatpinyo,James Hakim,Timothy P. Flanigan,Nagalingeswaran Kumarasamy,Thomas B. Campbell,Susan H. Eshleman +26 more
TL;DR: In this global clinical trial, pretreatment resistance and HIV-1 subtype were independently associated with virologic failure and should be considered whenever feasible.
Journal ArticleDOI
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial
Mina C. Hosseinipour,Gregory P. Bisson,Sachiko Miyahara,Xin Sun,Agnes Moses,Cynthia Riviere,Fredrick Kirui,Sharla. Badal-Faesen,David K. Lagat,Mulinda Nyirenda,Kogieleum Naidoo,James Hakim,Peter Mugyenyi,German Henostroza,Paul Leger,Javier R. Lama,Lerato Mohapi,Jorge Alave,Vidya Mave,Valdilea G. Veloso,Sandy Pillay,Nagalingeswaran Kumarasamy,Jing. Bao,Evelyn Hogg,Lynne Jones,Andrew R. Zolopa,Johnstone Kumwenda,Amita Gupta +27 more
TL;DR: The low mortality rate of the trial supports implementation of systematic tuberculosis screening and isoniazid preventive therapy in outpatients with advanced HIV disease and antiretroviral therapy in high-burden settings.
Journal ArticleDOI
Acceptability and feasibility of HIV self-testing among men who have sex with men in Peru and Brazil
Jonathan E. Volk,Sheri A. Lippman,Beatriz Grinsztejn,Javier R. Lama,Nilo Martinez Fernandes,Pedro Gonzales,Nancy A. Hessol,Susan Buchbinder +7 more
TL;DR: HIV self-testing with a blood-based assay was highly acceptable and feasible and may have the potential to increase testing frequency and to reach high-risk MSM not currently accessing HIV-testing services.
Journal ArticleDOI
Patterns and Correlates of PrEP Drug Detection Among MSM and Transgender Women in the Global iPrEx Study
Albert Y. Liu,David V. Glidden,Peter L. Anderson,K. Rivet Amico,Vanessa McMahan,Megha Mehrotra,Javier R. Lama,John MacRae,Juan Carlos Hinojosa,Orlando Montoya,Valdilea G. Veloso,Mauro Schechter,Esper G. Kallas,Suwat Chariyalerstak,Linda-Gail Bekker,Kenneth H. Mayer,Susan Buchbinder,Robert M. Grant,Robert M. Grant +18 more
TL;DR: Distinct patterns of study product use were identified, with a significant proportion demonstrating no drug detection at any visit, and greater drug detection among those reporting highest risk sexual practices is expected to increase the impact and cost- effectiveness of PrEP.